For Nigerian parents, the risk of Sickle Cell Disease (SCD) is a profound reality. You deserve to know your baby’s risk early, without compromising the pregnancy you cherish.
Gain Certainty TodayScreening available as early as 10 weeks.
With nearly 1 in 4 Nigerians carrying the sickle trait, the need for safe, accurate, and early prenatal screening is not just clinical—it’s personal. Standard procedures can involve risk, which is why we engineered a better way.
Introducing SickleClear™ NIPT—the Non-Invasive Prenatal Test specifically engineered for high-prevalence settings and validated on African genotypes.
A sophisticated blood test that screens for the Sickle Cell mutation (HbS).
Performed safely from 10 weeks of gestation.
Analyzes minute fragments of your baby’s cfDNA circulating in maternal blood.
It replaces the need for risky, invasive procedures.
We understand the unique concerns and hopes you carry. SickleClear™ NIPT offers a path to clarity and confidence, allowing you to embrace your pregnancy with greater peace of mind.
Our non-invasive approach ensures the safety of both mother and baby, providing crucial genetic insights early in your journey.
SickleClear™ delivers a clear risk assessment, not merely a statistical probability.
• High-Risk for Fetal HbSS (Affected)
• Low-Risk for Fetal HbSS (Unaffected or Carrier)
*Results are highly accurate, backed by 95-99% sensitivity and 95-100% specificity for fetal genotype differentiation in carrier mothers.
Knowing your baby’s status early is a profound investment. It is the beginning of a proactive care plan that can dramatically improve your child’s health outcomes.
Single, All-Inclusive Fee
This fee covers the entire high-fidelity process: